French firms call for action to boost industry in "crucial" presidential election year
This article was originally published in Scrip
Executive Summary
In the run-up to the French presidential elections next month, a group of domestic pharmaceutical companies has issued a "white paper" drawing the candidates' attention to the needs of an industry facing a severe public image problem, higher taxes and a complex set of procedures that it says are hindering new drugs' access to the market.